4.7 Article

AKT inhibitor, GSK690693, induces growth inhibition and apoptosis in acute lymphoblastic leukemia cell lines

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Reciprocal regulation of Notch and PI3K/Akt signalling in T-ALL cells in vitro

Elisabetta Calzavara et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2008)

Article Biochemistry & Molecular Biology

Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia

Teresa Palomero et al.

NATURE MEDICINE (2007)

Article Multidisciplinary Sciences

A transforming mutation in the pleckstrin homology domain of AKT1 in cancer

John D. Carpten et al.

NATURE (2007)

Review Multidisciplinary Sciences

Ras, PI(3)K and mTOR signalling controls tumour cell growth

Reuben J. Shaw et al.

NATURE (2006)

Article Oncology

Antitumor activity of ZSTK474, a new phosphatidylitiositol 3-kinase inhibitor

Shin-ichi Yaguchi et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)

Review Biotechnology & Applied Microbiology

Exploiting the PI3K/AKT pathway for cancer drug discovery

BT Hennessy et al.

NATURE REVIEWS DRUG DISCOVERY (2005)

Article Oncology

Expression of Akt (protein kinase B) and its isoforms in malignant lymphomas

GC Fillmore et al.

LEUKEMIA & LYMPHOMA (2005)

Review Oncology

The TCL1 family of oncoproteins: Co-activators of transformation

MA Teitell

NATURE REVIEWS CANCER (2005)

Article Biochemistry & Molecular Biology

Physiological functions of protein kinase B/Akt

ZZ Yang et al.

BIOCHEMICAL SOCIETY TRANSACTIONS (2004)

Review Oncology

Microenvironmental interactions and survival of CLL B-cells

IM Pedersen et al.

LEUKEMIA & LYMPHOMA (2004)

Article Multidisciplinary Sciences

Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia

AP Weng et al.

SCIENCE (2004)

Article Immunology

Akt is TCL-ish: implications for B-cell lymphoma

MR Gold

TRENDS IN IMMUNOLOGY (2003)